Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Byrnes

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Pediatric Pulmonology|January 4, 1998
Exhaled nitric oxide measurements in normal and asthmatic childrenC A Byrnes, S Dinarevic, E A Shinebourne, et al.
Pediatric Pulmonology|July 2, 2003
Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationshipsE A Edwards, R Metcalfe, D G Milne, et al.
Thorax|August 1, 1997
Effect of measurement conditions on measured levels of peak exhaled nitric oxideC A Byrnes, S Dinarevic, C A Busst, et al.
Clinical Therapeutics|September 1, 1995
Efficacy, tolerability, and effect on health-related quality of life of finasteride versus placebo in men with symptomatic benign prostatic hyperplasia: a community based study. CUSP Investigators. Community based study of ProscarC A Byrnes, A S Morton, C L Liss, et al.
Clinical Therapeutics|March 1, 1997
Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study. Primary Care Investigator Study GroupJ L Tenover, G A Pagano, A S Morton, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Combined analysis of two multicenter studies of finasteride 5 mg in the treatment of symptomatic benign prostatic hyperplasiaC A Byrnes, C L Liss, J L Tenover, et al.
Journal of Paediatrics and Child Health|November 2, 2002
Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infantsA M Vogel, D R Lennon, R Broadbent, et al.
Pediatric Pulmonology|January 7, 2005
Nitric oxide levels and ciliary beat frequency in indigenous New Zealand childrenE A Edwards, C Douglas, S Broome, et al.
Pediatric Pulmonology|September 22, 2012
Respiratory health outcomes 1 year after admission with severe lower respiratory tract infectionA A Trenholme, C A Byrnes, C McBride, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trialR Lindsay, F Cosman, R A Lobo, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Pediatric Pulmonology|January 4, 1998
Exhaled nitric oxide measurements in normal and asthmatic childrenC A Byrnes, S Dinarevic, E A Shinebourne, et al.
Pediatric Pulmonology|July 2, 2003
Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationshipsE A Edwards, R Metcalfe, D G Milne, et al.
Thorax|August 1, 1997
Effect of measurement conditions on measured levels of peak exhaled nitric oxideC A Byrnes, S Dinarevic, C A Busst, et al.
Clinical Therapeutics|September 1, 1995
Efficacy, tolerability, and effect on health-related quality of life of finasteride versus placebo in men with symptomatic benign prostatic hyperplasia: a community based study. CUSP Investigators. Community based study of ProscarC A Byrnes, A S Morton, C L Liss, et al.
Clinical Therapeutics|March 1, 1997
Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study. Primary Care Investigator Study GroupJ L Tenover, G A Pagano, A S Morton, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Combined analysis of two multicenter studies of finasteride 5 mg in the treatment of symptomatic benign prostatic hyperplasiaC A Byrnes, C L Liss, J L Tenover, et al.
Journal of Paediatrics and Child Health|November 2, 2002
Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infantsA M Vogel, D R Lennon, R Broadbent, et al.
Pediatric Pulmonology|January 7, 2005
Nitric oxide levels and ciliary beat frequency in indigenous New Zealand childrenE A Edwards, C Douglas, S Broome, et al.
Pediatric Pulmonology|September 22, 2012
Respiratory health outcomes 1 year after admission with severe lower respiratory tract infectionA A Trenholme, C A Byrnes, C McBride, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trialR Lindsay, F Cosman, R A Lobo, et al.
Pageof 3